SCHEMBL9687933

SCHEMBL9687933

O=C(NC(=O)c1c(O)cccc1Cl)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.53
BAZ1A Q9NRL2 1/20 0.51
P2RX1 P51575 2/20 0.49
KCNJ5 P48544 1/20 0.48
KCNJ3 P48549 1/20 0.48
P2RX4 Q99571 1/20 0.48
P2RX7 Q99572 1/20 0.48
TMPRSS4 Q9NRS4 1/20 0.48
MTOR P42345 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
RAB9A P51151 2/20 0.47
MAPT P10636 2/20 0.47
TLR7 Q9NYK1 2/20 0.47
TYK2 P29597 1/20 0.47
GAA P10253 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NPC1 O15118 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7599768 0.92 EPHX2 (0.58) EPHX2BAZ1AKCNJ5KCNJ3MTOR
SCHEMBL11479382 0.82 RORC (0.64) EPHX2TDP1RAB9AMAPTTLR7
Chlotrifmeuron SCHEMBL10868747 0.80 TDP1 (0.70) EPHX2KCNJ5KCNJ3TDP1RAB9A
Penfluron SCHEMBL117735 0.80 EPHX2 (0.60) EPHX2BAZ1AMTORRAB9AMAPT
SCHEMBL30499683 0.79 KDR (0.66) P2RX1P2RX4P2RX7TMPRSS4RAB9A
SCHEMBL7603216 0.79 KDR (0.66) P2RX1P2RX4P2RX7TMPRSS4RAB9A
SCHEMBL8401785 0.79 P2RX1 (0.74) EPHX2BAZ1AP2RX1P2RX4P2RX7
SCHEMBL7605653 0.79 RAB9A (0.65) EPHX2RAB9AMAPTGAANPSR1
SCHEMBL9687352 0.78 PPIA (0.59) KCNJ5KCNJ3TDP1GAAPPIA
SCHEMBL11244841 0.78 MAOA (0.51) TDP1RAB9AMAPTTYK2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166180-A Administering diphenyl substituted (thio)carbonyl(thio)urea derivatives DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1992-11-24 US disclosed
EP-0324521-A2 Method of treating haematologic diseases and pharmaceutical compositions to be used therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1989-07-19 EP disclosed